biochips

NEW YORK (GenomeWeb) – New molecular diagnostics platform firm InSilixa has completed a $13 million private financing round.

Fluidigm of South San Francisco, Calif., has received US Patent No.

By Justin Petrone
The Singapore Institute of Manufacturing Technology has established a new resource to help companies develop microfluidic devices, including biochips.

Companies developing array- or biochip-based molecular diagnostics received a shot in the arm earlier this month under the Internal Revenue Service's $1 billion Qualifying Therapeutic Discovery Project program.

While the majority of the new funding will support genome-wide association studies, also benefiting from the federal stimulus package are research projects focused on copy number-variation analysis, gene expression, and bioinformatics.

Released this week as a product and a service that uses either catalog or custom arrays, HybSelect initially targets users of the Illumina Genome Analyzer who want to sequence up to 9.5 megabases of genomic DNA.

The company is looking to differentiate itself from other players in the miRNA array market — such as Agilent Technologies, Life Technologies, Exiqon, and Febit — by stressing the "quality, performance, and affordability" of its OneArray platform.

New Product Watch

Premium

Febit, DNAStar, Premier Biosoft

Febit plans to debut the method at Cambridge Healthtech Institute's Next-Generation Sequencing conference in San Diego next month.

Funding Update

Premium

Recent NSF Awards in Proteomics and Protein Research

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.